Aesthetic Medical International Holdings Group (PAIYY) AI Stock Analysis

Aesthetic Medical International Holdings Group

(Other OTC:PAIYY)

Select Model

Rating:42Neutral

Price Target:$0.08▼(-19.15% Downside)

Action:reiterated

Date:06/24/26

The score is held down primarily by weak financial fundamentals, especially the negative equity position, ongoing losses, and inconsistent cash generation. Technicals are mixed to stretched, while valuation offers little support because earnings are still negative and no dividend yield is available.

Positive Factors

Gross margin strengthSustained gross margins in the mid‑40s to low‑50s indicate the core service offering retains pricing power and cost advantage. That margin buffer can absorb some SG&A volatility and supports a path to operating leverage if revenue stabilizes.

Negative Factors

Deteriorated balance sheetRising debt alongside negative shareholders' equity materially reduces financial flexibility and increases insolvency risk. Negative equity limits the company's ability to absorb further losses, raises creditor scrutiny, and constrains strategic options over the medium term.

Aesthetic Medical International Holdings Group (PAIYY) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $194.75K
Dividend Yield: ―
Average Volume (3M): 1,118
Price to Earnings (P/E): -0.0
Beta (1Y): -3.48
Revenue Growth: ―
EPS Growth: ―
Country: US
Employees: 1,139
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Aesthetic Medical International Holdings Group Business Overview & Revenue Model

Company Description

Aesthetic Medical International Holdings Group Ltd. engages in the provision of aesthetic medical services. It offers surgical and non-surgical treatments, cosmetic dentistry, and general healthcare services. The firm's treatments include eye surgery...

How the Company Makes Money

null

Aesthetic Medical International Holdings Group Financial Statement Overview

Summary

Revenue and margins have improved from earlier lows, but persistent net losses, negative equity, and volatile cash flow keep financial quality weak. The balance sheet is the main drag, with leverage and solvency risk outweighing the partial operational recovery.

Income Statement

45Neutral

Balance Sheet

28Negative

Cash Flow

52Neutral

Financial statement breakdown
Breakdown	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2021
Income Statement
Total Revenue	703.16M	755.67M	682.59M	670.09M	645.59M
Gross Profit	325.14M	337.79M	322.05M	355.59M	269.50M
EBITDA	62.38M	73.33M	25.31M	-11.05M	-554.95M
Net Income	-51.89M	-19.95M	-37.43M	-76.25M	-586.62M
Balance Sheet
Total Assets	511.22M	486.22M	560.66M	546.37M	576.94M
Cash, Cash Equivalents and Short-Term Investments	65.40M	42.84M	62.34M	12.16M	39.29M
Total Debt	280.76M	179.30M	244.55M	393.10M	405.91M
Total Liabilities	554.48M	476.88M	527.03M	672.25M	763.36M
Stockholders Equity	-20.61M	30.46M	48.89M	-113.66M	-156.67M
Cash Flow
Free Cash Flow	-23.01M	48.88M	18.83M	-76.80M	17.65M
Operating Cash Flow	-16.29M	79.67M	74.29M	-75.13M	51.09M
Investing Cash Flow	-405.63K	-30.32M	-52.25M	3.11M	-11.53M
Financing Cash Flow	37.62M	-68.55M	29.06M	45.55M	-45.23M

Aesthetic Medical International Holdings Group Technical Analysis

Technical Analysis SentimentPositive

Last Price0.09

Price Trends

50DMA0.02Positive

100DMA0.02Positive

200DMA0.03Positive

Market Momentum

MACD0.00Negative

RSI97.01Negative

STOCH15.86Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAIYY, the sentiment is Positive. The current price of 0.09 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.02, and above the 200-day MA of 0.03, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 97.01 is Negative, neither overbought nor oversold. The STOCH value of 15.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAIYY.

Aesthetic Medical International Holdings Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

PAIYY against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HSCS	47Neutral	$16.45M	-0.93	-816.25%	―	-27.70%	61.44%
TNMG	42Neutral	$2.96M	-0.03	-249.02%	―	-7.16%	71.12%
PAIYY	42Neutral	$598.86K	-0.02	-1054.33%	―	―	―
NCNA	33Underperform	$4.35M	-0.25	-41.95%	―	―	99.50%

* Healthcare Sector Average

Performance Comparison

PAIYY and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
PAIYY	Aesthetic Medical International Holdings Group Ltd.	0.09	-0.08	-44.71%
NCNA	Nucana Plc	0.98	-2.65	-73.00%
CELZ	Creative Medical Technology Holdings, Inc.	0.62	-2.23	-78.14%
HSCS	Heart Test Laboratories, Inc.	2.99	0.16	5.65%
TNMG	TNL Mediagene	4.15	-41.96	-91.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jun 23, 2026

Aesthetic Medical International Holdings Group AI Stock Analysis